Search clinical trials for: BMS-650032 or Placebo
Total 1231 results
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Australia, United States, Italy, Argentina, Canada, Mexico, India, Peru, Spain, Denmark, France, Singapore, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States
-
BioMarin PharmaceuticalCompletedMPS IV AUnited States, Canada, France, United Kingdom, Taiwan, Argentina, Colombia, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, Germany, Portugal, Italy, Qatar
-
Yale UniversityHeffter Research Institute; Ceruvia Lifesciences; CH TAC LLCCompleted
-
Mclean HospitalUniversity of MinnesotaCompletedSchizophrenia | Bipolar Disorder
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
Jazz PharmaceuticalsCompletedUlcerative ColitisUnited Kingdom
-
Glycotope GmbHCompletedSolid Tumor, AdultGermany, Italy, Spain
-
Axon Neuroscience SECompletedAlzheimer DiseaseAustria
-
ActelionCompletedPulmonary Arterial Hypertension | Pulmonary Hypertension | Ayerza SyndromeUnited States
-
University of California, Los AngelesOlive View-UCLA Education & Research InstituteNot yet recruitingEpilepsy | Hypertension | Hyperlipidemia (E.G., Hypercholesterolemia)
-
Hellenic Institute for the Study of SepsisActive, not recruitingSepsisGreece, Germany, Netherlands, Romania, Switzerland
-
GeneScience Pharmaceuticals Co., Ltd.Completed
-
University of OklahomaNational Center for Research Resources (NCRR)CompletedDiabetes Mellitus, Adult OnsetUnited States
-
AmgenTerminatedSystemic Lupus Erythematosus | Cutaneous Lupus | Lupus | Discoid LupusUnited States
-
Federal University of UberlandiaConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
EMSRecruitingEosinophilic EsophagitisBrazil
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
AstraZenecaBristol-Myers SquibbCompleted
-
UCB PharmaCompletedRheumatoid ArthritisUnited States, Belgium, United Kingdom
-
University of ZurichNovartis PharmaceuticalsCompleted
-
University Health Network, TorontoMiltenyi Biotec, Inc.CompletedHeart Failure | Coronary Artery Bypass Surgery | Heart AttackCanada
-
University of California, San FranciscoCompletedMultiple SclerosisUnited States
-
PfizerCompleted
-
University of Illinois at ChicagoNational Institute on Drug Abuse (NIDA)Completed
-
J2H BiotechCompletedNon-alcoholic SteatohepatitisKorea, Republic of
-
Bristol-Myers SquibbCompletedDepressionFrance, Sweden, United States, South Africa, Canada, Finland
-
Vanda PharmaceuticalsCompletedPharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With EthanolCanada
-
University Hospital, ToulouseCompletedMultiple System AtrophyFrance
-
University of MiamiTerminated
-
Hartford HospitalCompletedConstipationUnited States
-
Janssen Sciences Ireland UCCompletedHepatitis BUnited States, Korea, Republic of, France, Belgium, Italy, Taiwan, United Kingdom, Thailand, Malaysia, China, Spain, Canada, Germany, Japan, Russian Federation, Turkey, Ukraine, Poland, Hong Kong
-
Beth Israel Deaconess Medical CenterAmerican Diabetes AssociationCompletedHIV LipodystrophyUnited States
-
University Hospital, Gentofte, CopenhagenThe Novo Nordisk Foundation Center for Basic Metabolic ResearchRecruitingHypoglycemia | Type1diabetes | Type 1 DiabetesDenmark
-
Institute for Clinical and Experimental MedicineRecruitingKetosis | Acute Heart Failure | Hemodynamic Instability | Low Cardiac Output SyndromeCzechia
-
Danish Headache CenterCompleted
-
NICHD Neonatal Research NetworkNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingNeonatal | Neurodevelopmental Impairment | Neurocognitive | NeuroprotectiveUnited States
-
Bristol-Myers SquibbRecruiting
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
Coordinación de Investigación en Salud, MexicoTerminatedQuality of Life | Head and Neck Squamous Cell Carcinoma | Radiotherapy; ComplicationsMexico
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Bristol-Myers SquibbCompletedDiabetic Peripheral Neuropathic PainUnited States, France
-
Bristol-Myers SquibbCompleted
-
Steadman Philippon Research InstituteUnited States Department of Defense; Office of Naval Research (ONR)RecruitingOsteoarthritis, KneeUnited States
-
SF Research Institute, Inc.Ixoreal Biomed Inc.Active, not recruiting
-
Kyowa Kirin Co., Ltd.CompletedParkinson's DiseaseJapan
-
Concordia University, MontrealCompleted